Merck’s Keytruda lands new colorectal cancer nod, its 2nd biomarker-based OK this month chelfand Tue, 06/30/2020 – 04:00

The study will assess the potential of the drug in patients hospitalised with severe SARS-CoV-2 infection and pneumonia

Almost all cancer trials in Scotland are on hold amid the coronavirus pandemic

The therapy marks Roche’s first combination of two monoclonal antibodies administered in a single subcutaneous injection

The collaboration hopes to empower patients to take more control of their own health

The funds will enable in-house drug discovery across a number of therapeutic areas including cancer and neurodegeneration

Updated Date: Mon, 22 Jun 2020 00:00:00 EDT

Updated Date: Mon, 22 Jun 2020 00:00:00 EDT

Updated Date: Mon, 22 Jun 2020 00:00:00 EDT

Updated Date: Mon, 22 Jun 2020 00:00:00 EDT